Clin2
NCT07179237Likely a fitRecruiting

Testing carminal for H. pylori stomach infection

H Pylori GastritisH Pylori InfectionH Pylori EradicationGastritis Associated With Helicobacter PyloriGastric Mucosal Lesion

Part of Digestive system clinical trials.

This trial tests a new medicine called carminal for people with stomach inflammation caused by H. pylori bacteria. It aims to see if the drug can help improve symptoms like indigestion and get rid of the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have indigestion symptoms like pain, bloating, or burning in your stomach
  • You have been diagnosed with H. pylori stomach infection through an upper endoscopy with biopsy
  • You are not currently pregnant, breastfeeding, or planning to become pregnant during the study
  • You do not have an active ulcer, previous stomach surgery, or a history of cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012785Not yet recruiting
Brewer's yeast and minocycline for new H. pylori patients

This trial tests a treatment combining a probiotic (Saccharomyces boulardii) with an antibiotic (minocycline) for people who have never been treated for H. pylori infection. It aims to see if this combination works well and is safe.

Nanjing, Jiangsu
NCT04713670Recruiting· Phase 4
Tested medicines to cure new H. pylori infection

This trial compares different stomach-medicine combinations to eliminate a new (first-time) H. pylori infection. It may help find the most effective treatment approach for people who have never tried eradication therapy before.

Taipei
NCT07344506Recruiting· Phase 4
Cure H. pylori: New combination therapy for stomach infection

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Karachi
NCT07606833Not yet recruiting· Phase 3
Testing a New Medicine to Cure Stomach Bacteria Infection

This trial tests whether a new medication called anaprazole sodium, combined with other antibiotics and bismuth, can effectively cure a common stomach bacteria infection called Helicobacter pylori (H. pylori). If you have this infection and have never been treated for it before, this study might help you while contributing to medical knowledge.

Shenzhen, Guangdong
NCT05061732Recruiting· Phase 4
Treatment and follow-up study for Helicobacter pylori infection

This trial studies how to eradicate Helicobacter pylori (a germ in the stomach) and monitor follow-up results after treatment. You may be a candidate if you have confirmed infection and have not taken certain stomach medicines or antibiotics recently.

Shanghai, Shanghai Municipality
NCT07068607Recruiting· Phase 4
Comparing two treatments for H. pylori infection

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Xi'an, Shaanxi

Hear when a new H. Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.